You are precisely correct.
Rob Telson has done this before. He knows what the value of the IP is and what the cost of the 2 devices need to be.
From past engineering experience, this cost is negligible based on the upside the customer can gain, and not forgetting the support that comes with it.
I'd rather listen to Rob, than a downramping muppet!
- Forums
- ASX - By Stock
- BRN
- Ann: Taking Orders of Akida AI
Ann: Taking Orders of Akida AI, page-155
-
- There are more pages in this discussion • 113 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
|
|||||
Last
17.0¢ |
Change
-0.005(2.86%) |
Mkt cap ! $333.0M |
Open | High | Low | Value | Volume |
18.0¢ | 18.0¢ | 16.8¢ | $1.174M | 6.869M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 185137 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 920196 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 185137 | 0.170 |
59 | 1704182 | 0.165 |
70 | 1482354 | 0.160 |
24 | 1146919 | 0.155 |
75 | 1949972 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 920196 | 12 |
0.180 | 1575617 | 38 |
0.185 | 1198216 | 25 |
0.190 | 1209016 | 21 |
0.195 | 914971 | 14 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online